Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SUPT7L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TES - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFYC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IPO5P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LINC01561 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EMID1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IDH3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HRH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXE3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
EDNRB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
QKI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC400684 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DACT3-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC39A9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC33A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFNAR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on